Niagen Bioscience (NAGE) Interest Coverage Ratio Growth (1y) (2011 - 2022)
Niagen Bioscience (NAGE) Interest Coverage Ratio Growth (1y) (2011 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
67.94% |
| 10 |
Niagen Bioscience |
280.11 Mn |
213.56 Mn |
19.98 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2022 |
-4.00% |
| Jun 30, 2022 |
-38.00% |
| Mar 31, 2022 |
-149.44% |
| Dec 31, 2021 |
-55.41% |
| Sep 30, 2021 |
-166.89% |
| Jun 30, 2021 |
-201.27% |
| Sep 30, 2020 |
-906.74% |
| Jun 30, 2020 |
-1,130.28% |
| Sep 30, 2019 |
97.70% |
| Jun 30, 2019 |
89.77% |
| Sep 30, 2018 |
-1,253.27% |
| Jun 30, 2018 |
-65.88% |
| Mar 31, 2018 |
-201.46% |
| Dec 30, 2017 |
-68.64% |
| Sep 30, 2017 |
82.74% |
| Jul 1, 2017 |
-6,810.99% |
| Apr 1, 2017 |
-37,322.52% |
| Dec 31, 2016 |
-4,977.28% |
| Oct 1, 2016 |
-42,075.32% |
| Jul 2, 2016 |
178.53% |
